BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19235784)

  • 1. PET-CT in recurrent head neck cancers: a study to evaluate impact on patient management.
    Pantvaidya GH; Agarwal JP; Deshpande MS; Rangarajan V; Singh V; Kakade A; D'Cruz AK
    J Surg Oncol; 2009 Oct; 100(5):401-3. PubMed ID: 19235784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study.
    Scott AM; Gunawardana DH; Bartholomeusz D; Ramshaw JE; Lin P
    J Nucl Med; 2008 Oct; 49(10):1593-600. PubMed ID: 18794254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
    Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in surgical management of the node-positive neck after chemoradiation.
    Lango MN; Myers JN; Garden AS
    Semin Radiat Oncol; 2009 Jan; 19(1):24-8. PubMed ID: 19028342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol.
    Berson AM; Stein NF; Riegel AC; Destian S; Ng T; Tena LB; Mitnick RJ; Heiba S
    Med Dosim; 2009; 34(1):30-5. PubMed ID: 19181253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.
    Waltonen JD; Ozer E; Hall NC; Schuller DE; Agrawal A
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1024-9. PubMed ID: 19841343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients.
    Fleming AJ; Johansen ME
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):127-34. PubMed ID: 18327031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.
    Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA
    J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma.
    Park JY; Kim EN; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2008 May; 109(2):255-62. PubMed ID: 18308380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for PET/CT in the head and neck.
    Agarwal V; Branstetter BF; Johnson JT
    Otolaryngol Clin North Am; 2008 Feb; 41(1):23-49, v. PubMed ID: 18261525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.
    Hillner BE; Siegel BA; Shields AF; Liu D; Gareen IF; Hunt E; Coleman RE
    J Nucl Med; 2008 Dec; 49(12):1928-35. PubMed ID: 18997054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short- to mid-term evaluation of CT-guided 125I brachytherapy on recurrent or metastatic head and neck cancers].
    Huang ZL; Li CX; Zhang FJ; Jiao DC; Wu PH; Zhang T; Wang JJ; Duan GF; Wu YX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):321-4. PubMed ID: 19563709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
    Gao S; Li S; Yang X; Tang Q
    Oral Oncol; 2014 Mar; 50(3):163-7. PubMed ID: 24368204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.